Your browser doesn't support javascript.
loading
Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells.
Pilli, Tania; Cantara, Silvia; Marzocchi, Carlotta; Pacini, Furio; Prabhakar, Bellur S; Castagna, Maria Grazia.
Afiliação
  • Pilli T; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy.
  • Cantara S; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy.
  • Marzocchi C; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy.
  • Pacini F; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy.
  • Prabhakar BS; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, USA.
  • Castagna MG; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy. m.g.castagna@ao-siena.toscana.it.
Endocrine ; 67(1): 117-123, 2020 01.
Article em En | MEDLINE | ID: mdl-31377969

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Anaplásico da Tireoide Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Anaplásico da Tireoide Idioma: En Ano de publicação: 2020 Tipo de documento: Article